Referenz:
20200200
Veröffentlichungsdatum: 4 Juni 2020
Veröffentlichungsdatum: 4 Juni 2020
Projektträger – zwischengeschaltetes Finanzinstitut
CREDIT AGRICOLE SAOrt
Beschreibung
The operation consists in a Multiple Beneficiary Intermediated Loan (MBIL) focusing on the healthcare and pharmaceutical sector in France. 20% will be dedicated to regions where access to medical experts is sub-optimal/underserved.
Ziele
The aim is to facilitate access to long-term finance for projects carried out by professionals and small and medium size enterprises (SMEs) in the healthcare and pharmaceutical sectors.
Sektor(en)
- Durchleitungsdarlehen - Durchleitungsdarlehen
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 250 million
Gesamtkosten (voraussichtlicher Betrag)
not applicable
Umweltaspekte
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Auftragsvergabe
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Projektstatus
Unterzeichnet - 27/10/2020